Sean Dodge
Stock Analyst at RBC Capital
(2.14)
# 2,802
Out of 4,883 analysts
133
Total ratings
34.02%
Success rate
-1.55%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $4.06 | +47.97% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $2.39 | +46.44% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $164.65 | +63.98% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $8.35 | +43.71% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $150.82 | +74.38% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $11.73 | +44.93% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $29.08 | +10.04% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $13.23 | -54.65% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $101.28 | +3.67% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $11.63 | +46.24% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $38.67 | -12.08% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $22.68 | -38.27% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $5.06 | +97.82% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.92 | +27.74% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $14.94 | -6.26% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $177.08 | -81.36% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $0.48 | +37,167.08% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $4.06
Upside: +47.97%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $2.39
Upside: +46.44%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $164.65
Upside: +63.98%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $8.35
Upside: +43.71%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $150.82
Upside: +74.38%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $11.73
Upside: +44.93%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $29.08
Upside: +10.04%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $13.23
Upside: -54.65%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $101.28
Upside: +3.67%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $11.63
Upside: +46.24%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $38.67
Upside: -12.08%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $22.68
Upside: -38.27%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $5.06
Upside: +97.82%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $21.92
Upside: +27.74%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $14.94
Upside: -6.26%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $177.08
Upside: -81.36%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $0.48
Upside: +37,167.08%